Carcinoid – Care to Care's Clinical Criteria

CT or MRI of Abdomen and Pelvis

CT of chest if appropriate

Somatostatin (Octreoscan) scintigraphy (nuclear scan)

Surveillance Imaging

Local or regional disease

CT or MRI of Abdomen and Pelvis at least 3 months after treatment, then every 6 – 12 months for 10 years as clinically indicated

Metastatic Disease

scans every 3 – 12 months

Less than 1 cm require no follow up

1 -2 cm rectal MRI at 6 and 12 months, then as clinically indicated

Greater than 2cm CT or MRI of Abdomen and Pelvis at least 3 months after treatment, then every 6 – 12 months for 10 years

NCCN Guidelines Cacrinoid Tumors v 1.2012 accessed 1/03/12

Ganeshan D, Bhosale P, Yang T, Kundra V; Imaging features of carcinoid tumors of the gastrointestinal tract; AJR Am J Roentgenol. 2013 Oct;201(4):773-86.

Dromain C, de Baere T, et al; Detection of liver metastases from endocrine tumors: a prospective comparison of somatostatin receptor scintigraphy, computed tomography, and magnetic resonance imaging. J Clin Oncol. 2005;23(1):70.

NCCN Guidelines Version 1.2015 Neuroendocrine Tumors of the Gastrointestinal Tract, Lung and Thymus (Carcinoid Tumors)